Every year, CHDI hosts a unique conference series focused on drug discovery and development for Huntington’s disease, and draws participants and speakers from the biotech and pharmaceutical sectors as well as academia and research institutions. The conference is intended as a forum where all participants can share ideas, learn about new disciplines, network with colleagues and build new collaborative partnerships. We are indebted to all of the conference speakers, and especially grateful to those who are able to make their presentations available here for a wider audience.
Watch as information from the 2018 Conference is summarized in this informative video:
HSC CEO, Bev Heim-Myers, attended the 2018 Conference. Read her summaries here:
HDBuzz contributors also attended the 2018 Conference. Read their summaries here: